-Reuters
Timber Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards
Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE:TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan